Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan-论文-万方医学网

首页> > Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan

导出原文传递

翻译打印收藏纠错

第一作者： Mekahli D

作者： Mekahli D ^[1] ; Guay-Woodford L.M ; Cadnapaphornchai M.A ; Goldstein S.L ; Dur A ; Jiang H ; Jadhav P ; Debuque L.

作者单位： PKD Research Group, Laboratory of Ion Channel Research, Department of Cellular and Molecular ^[1]

关键词 ADPKD Autosomal dominant polycystic kidney disease Chronic kidney disease Kidney volume Pediatric Risk assessment Tolvaptan

发布时间 2024-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan

相似文献

同项目论文

相关期刊

检索历史 清除

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan

相似文献

同项目论文

相关期刊

检索历史清除